Evidence map›Paper›PMID 19619554›Full record

ArticleJournal of immunological methods2009

Molecular characterization of hybridoma subclones spontaneously switching at high frequencies in vitro.

Maria D Iglesias-Ussel, Jiri Zavadil, Matthew D Scharff

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maria D Iglesias-UsselDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Jiri Zavadil
Matthew D Scharff
Albert Einstein College of Medicine · USNYU Langone Health · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
Mismatch repair in V region mutation and isotype switchingR01CA102705 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 2003 to 2013
$3.2M
NCI NIH HHS CA102705NCI NIH HHS CA72649NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA102705NIAID NIH HHS AI57158NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

The hybridoma technology allows the production of large quantities of specific antibodies of a single isotype. Since different isotypes have special effector functions and are distributed distinctively throughout the body, it is often useful to have a library of switch variants from the original monoclonal antibody. We have shown previously that forced expression of activation induced cytidine deaminase (AID) in hybridomas increased their very low frequency of class switch recombination (CSR) in vitro only approximately 7-13 fold. Since we had previously identified rare hybridoma subclones that spontaneously switched at more than 100 times higher frequencies, we have now examined those higher switching variants to search for ways to further increase the frequency of isotype switching in vitro. AID was not responsible for the approximately 100 fold increase in CSR, so we used whole-genome gene expression profiling to provide a platform for studying candidate molecular pathways underlying spontaneous CSR in hybridomas.

Indexed as

AnimalsAntibodies, MonoclonalGene Expression ProfilingGene Expression RegulationGene Rearrangement, B-LymphocyteHybridomasMiceOligonucleotide Array Sequence Analysisp-AzobenzenearsonateAntibodies, Monoclonalp-Azobenzenearsonate

Identifiers

PMID19619554
PMCPMC2762006
OpenAlexW2026640354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.